{"component": "contracts", "props": {"contracts": [{"intro": "This SUPPLY AGREEMENT (this \"Agreement\"), dated as of May 8, 2009 (the \"Effective Date''), is by and between BIOZONE LABORATORIES, INC., a California corporation ('Supplier\"), and ____, LLC, an ____ limited liability company (\"____\").", "id": "4WJ3J0gecnR", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153612000608/q1100600_ex10-46.htm", "category_name": "Supply Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "July 2nd, 2012", "published": true, "pretty": null, "uri": "/contracts/4WJ3J0gecnR", "title": "SUPPLY AGREEMENT", "group_id": "4WJ3J0gecnR", "group_samples": [{"label": "Supply Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/4WJ3J0gecnR", "published": true}], "group_size": 1, "tags": [{"name": "Supply Agreement", "type": "category", "uri": "/contracts/tagged/supply-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Arizona", "type": "jurisdiction", "uri": "/contracts/tagged/arizona-us"}]}, {"intro": "The undersigned is, or is anticipated to be, a beneficial owner of shares of capital stock, or securities convertible into or exercisable or exchangeable for the capital stock (each, a \u201cCompany Security\u201d) of Biozone Pharmaceuticals, Inc., a Nevada corporation (the \u201cCompany\u201d). The undersigned understands that the Company is acquiring certain businesses (the \u201cTarget Companies\u201d) in consideration for an aggregate purchase price of 21,000,000 shares (the \u201cShares\u201d) of the Company\u2019s common stock (the \u201cPurchase\u201d) from the undersigned.and other owners of the Target Companies. The undersigned understands that the Company will proceed with the Purchase in reliance on this Letter Agreement to be signed by each of the owners of the Target Companies.", "id": "4jTlGPG6RhF", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153611000018/exhibit10_5.htm", "category_name": "Lock-Up Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "July 7th, 2011", "published": true, "pretty": null, "uri": "/contracts/4jTlGPG6RhF", "title": "LOCK-UP AGREEMENT", "group_id": "4jTlGPG6RhF", "group_samples": [{"label": "Lock Up Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/4jTlGPG6RhF", "published": true}], "group_size": 1, "tags": [{"name": "Lock-Up Agreement", "type": "category", "uri": "/contracts/tagged/lock-up-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Services-business services, nec", "type": "industry", "uri": "/contracts/tagged/services-business-services-nec"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS SECURITIES PURCHASE AGREEMENT (the \u201cAgreement\u201d) entered into as of this 17th day of March, 2015 (the \u201cEffective Date\u201d) by and between the parties on the signature page to this Agreement (each, a \u201cPurchaser\u201d), Cocrystal Pharma, Inc., a Delaware corporation (\u201cCOCP\u201d) (collectively, the Purchaser and COCP are the \u201cParties\u201d).", "id": "56OMvwCxmRu", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588915001048/ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "March 26th, 2015", "published": true, "pretty": null, "uri": "/contracts/56OMvwCxmRu", "title": "FORM OF SECURITIES PURCHASE AGREEMENT", "group_id": "56OMvwCxmRu", "group_samples": [{"label": "Securities Purchase Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/56OMvwCxmRu", "published": true}], "group_size": 1, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "THIS SECURITIES PURCHASE AGREEMENT (the \u201cAgreement\u201d) entered into as of this ____ day of July, 2026 (the \u201cEffective Date\u201d) by and between OPKO Health, Inc., a Delaware corporation (the \u201cPurchaser\u201d), and Cocrystal Pharma, Inc., a Delaware corporation (\u201cCOCP\u201d) (collectively, the Purchaser and COCP are the \u201cParties\u201d).", "id": "5CSHjJAxWuF", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000149315226035743/ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "August 3rd, 2026", "published": true, "pretty": null, "uri": "/contracts/5CSHjJAxWuF", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "5CSHjJAxWuF", "group_samples": [{"label": "Securities Purchase Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/5CSHjJAxWuF", "published": true}], "group_size": 1, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "This Agreement (this \u201cAgreement\u201d) is effective as of January 2, 2019 (the \u201cEffective Date\u201d), and is entered into by and between Cocrystal Pharma, Inc., a corporation organized and existing under the laws of Delaware (\u201cCocrystal\u201d) and Merck Sharp & Dohme Corp., a corporation organized and existing under the laws of New Jersey (\u201cMerck\u201d).", "id": "5QQM2d6D8Xe", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000149315219004386/ex10-12.htm", "category_name": "Exclusive License and Research Collaboration Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "April 1st, 2019", "published": true, "pretty": null, "uri": "/contracts/5QQM2d6D8Xe", "title": "EXCLUSIVE LICENSE AND RESEARCH COLLABORATION AGREEMENT by and between COCRYSTAL PHARMA, INC. and MERCK SHARP & DOHME CORP.", "group_id": "5QQM2d6D8Xe", "group_samples": [{"label": "Exclusive License and Research Collaboration Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/5QQM2d6D8Xe", "published": true}], "group_size": 1, "tags": [{"name": "Exclusive License and Research Collaboration Agreement", "type": "category", "uri": "/contracts/tagged/exclusive-license-and-research-collaboration-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS SUBSCRIPTION AGREEMENT (this \u201cAgreement\u201d) is made as of the last date set forth on the signature page hereof between Biozone Pharmaceuticals, Inc., a Nevada corporation (the \u201cCompany\u201d), and the undersigned (the \u201cSubscriber\u201d).", "id": "5am2kctOZYn", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153613000342/q1101065_ex10-1.htm", "category_name": "Subscription Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "April 18th, 2013", "published": true, "pretty": null, "uri": "/contracts/5am2kctOZYn", "title": "SUBSCRIPTION AGREEMENT", "group_id": "5am2kctOZYn", "group_samples": [{"label": "Subscription Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/5am2kctOZYn", "published": true}], "group_size": 1, "tags": [{"name": "Subscription Agreement", "type": "category", "uri": "/contracts/tagged/subscription-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This First Amendment to Executive Employment Agreement (this \"Amendment\") between Cocrystal Pharma, Inc., a Delaware corporation (f/k/a Biozone Pharmaceuticals, Inc.) (including its successors and assigns, the \"Company\"), and Dr. Sam Lee (the \"Executive\") is dated as of February 23, 2015. This Amendment amends the Executive Employment Agreement dated as of January 2, 2014 by and between the Company and Executive (the \"Employment Agreement\"). Capitalized terms used but not defined herein shall have the meanings given to such terms in the Employment Agreement. All references to Sections herein shall be references to such Sections in the Employment Agreement unless otherwise noted.", "id": "5kvAEmLMsrH", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588915001157/ex10-6.htm", "category_name": "Executive Employment Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "March 31st, 2015", "published": true, "pretty": null, "uri": "/contracts/5kvAEmLMsrH", "title": "FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "5kvAEmLMsrH", "group_samples": [{"label": "Executive Employment Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/5kvAEmLMsrH", "published": true}], "group_size": 1, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Washington", "type": "jurisdiction", "uri": "/contracts/tagged/washington-us"}]}, {"intro": "This LICENSE AGREEMENT (this \u201cAgreement\u201d), the effective date of which is February 12, 2020 (hereinafter \u201cEffective Date\u201d) is made by and between Kansas State University Research Foundation, a non-profit Kansas corporation having its principal office at 2005 Research Park Circle, Manhattan, Kansas, USA, 66502 (hereinafter referred to as \u201cFoundation\u201d) and Cocrystal Pharma, Inc., a corporation having its principal office at 19805 North Creek Parkway, Bothell, WA 98011 (hereinafter referred to as \u201cLicensee\u201d)(each of Foundation and Licensee, a \u201cParty\u201d and together the \u201cParties\u201d).", "id": "6VPMUibcVxc", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000149315220008508/ex10-7.htm", "category_name": "License Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "May 13th, 2020", "published": true, "pretty": null, "uri": "/contracts/6VPMUibcVxc", "title": "LICENSE AGREEMENT BETWEEN Cocrystal Pharma, Inc. AND KANSAS STATE UNIVERSITY RESEARCH FOUNDATION LICENSE AGREEMENT", "group_id": "6VPMUibcVxc", "group_samples": [{"label": "License Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/6VPMUibcVxc", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Kansas", "type": "jurisdiction", "uri": "/contracts/tagged/kansas-us"}]}, {"intro": "THIS RESEARCH AND COLLABORATION AGREEMENT (the \u201cAgreement\u201d) is made and entered into as of September 13, 2011 (\u201cEffective Date\u201d) by and between:", "id": "6c1wO0pMAQF", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588914002511/ex10-21.htm", "category_name": "Research and Collaboration Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "August 14th, 2014", "published": true, "pretty": null, "uri": "/contracts/6c1wO0pMAQF", "title": "RESEARCH AND COLLABORATION AGREEMENT between TEVA PHARMACEUTICAL INDUSTRIES LIMITED and COCRYSTAL DISCOVERY, INC. Dated as of September 13, 2011", "group_id": "6c1wO0pMAQF", "group_samples": [{"label": "Research and Collaboration Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/6c1wO0pMAQF", "published": true}], "group_size": 1, "tags": [{"name": "Research and Collaboration Agreement", "type": "category", "uri": "/contracts/tagged/research-and-collaboration-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "SUBSCRIPTION AGREEMENT (this \u201cAgreement\u201d) made as of October [ ], 2011 between BioZone Pharmaceuticals, Inc., a Delaware corporation (the \u201cCompany\u201d) and each of the Subscribers identified on the signature pages hereto (including their respective successors and assigns, each a \u201cSubscriber,\u201d and collectively, the \u201cSubscribers\u201d).", "id": "7EzHUvi997p", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153611000363/q1100221_ex10-1.htm", "category_name": "Subscription Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "November 4th, 2011", "published": true, "pretty": null, "uri": "/contracts/7EzHUvi997p", "title": "SUBSCRIPTION AGREEMENT", "group_id": "7EzHUvi997p", "group_samples": [{"label": "Subscription Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/7EzHUvi997p", "published": true}], "group_size": 1, "tags": [{"name": "Subscription Agreement", "type": "category", "uri": "/contracts/tagged/subscription-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS SECURITIES PURCHASE AGREEMENT (the \u201cAgreement\u201d) entered into as of this 28 day of October, 2025 (the \u201cEffective Date\u201d) by and between the parties on the signature page to this Agreement (each, a \u201cPurchaser\u201d), and Cocrystal Pharma, Inc., a Delaware corporation (\u201cCOCP\u201d) (collectively, the Purchasers and COCP are the \u201cParties\u201d).", "id": "7FaPhV1qDOP", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000149315225020143/ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "October 30th, 2025", "published": true, "pretty": null, "uri": "/contracts/7FaPhV1qDOP", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "7FaPhV1qDOP", "group_samples": [{"label": "Securities Purchase Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/7FaPhV1qDOP", "published": true}], "group_size": 1, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "This Indemnification Agreement (the \u201cAgreement\u201d) is entered into as of this 2nd day of January, 2014, by and between Biozone Pharmaceuticals, Inc., a Nevada corporation (the \u201cCompany\u201d), and __________ (the \u201cIndemnitee\u201d) and replaces any and all Indemnification Agreements previously entered into between the Parties:", "id": "7S9AQ1DQu0p", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588914001020/ex10-13.htm", "category_name": "Indemnification Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "March 31st, 2014", "published": true, "pretty": null, "uri": "/contracts/7S9AQ1DQu0p", "title": "INDEMNIFICATION AGREEMENT", "group_id": "7S9AQ1DQu0p", "group_samples": [{"label": "Indemnification Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/7S9AQ1DQu0p", "published": true}], "group_size": 1, "tags": [{"name": "Indemnification Agreement", "type": "category", "uri": "/contracts/tagged/indemnification-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Nevada", "type": "jurisdiction", "uri": "/contracts/tagged/nevada-us"}]}, {"intro": "This LICENSE AGREEMENT (this \u201cAgreement\u201d), the effective date of which is April 1, 2020 (hereinafter \u201cEffective Date\u201d) is made by and between Kansas State University Research Foundation, a non-profit Kansas corporation having its principal office at 2005 Research Park Circle, Manhattan, Kansas, USA, 66502 (hereinafter referred to as \u201cFoundation\u201d) and Cocrystal Pharma, Inc., a corporation having its principal office at 19805 North Creek Parkway, Bothell, WA 98011 (hereinafter referred to as \u201cLicensee\u201d) (each of Foundation and Licensee, a \u201cParty\u201d and together the \u201cParties\u201d).", "id": "7brYJXt9Dia", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000149315220014811/ex10-1.htm", "category_name": "License Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "August 6th, 2020", "published": true, "pretty": null, "uri": "/contracts/7brYJXt9Dia", "title": "LICENSE AGREEMENT", "group_id": "7brYJXt9Dia", "group_samples": [{"label": "License Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/7brYJXt9Dia", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Kansas", "type": "jurisdiction", "uri": "/contracts/tagged/kansas-us"}]}, {"intro": "THIS CONTRACT CHIEF FINANCIAL OFFICER AGREEMENT (the \u201cAGREEMENT\u2019) is dated as of theday of February, 2017. It is made and entered into by and between Cocrystal Pharma, Inc., a Delaware corporation, located at 1860 Montreal Road, Tucker, Georgia 30084 (\u201cCompany\u201d), and James J. Martin (\u201cContract CFO\u201d).", "id": "8X47HMp40R2", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000165495417001453/ex10-1.htm", "category_name": "Contract Chief Financial Officer Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "February 24th, 2017", "published": true, "pretty": null, "uri": "/contracts/8X47HMp40R2", "title": "CONTRACT CHIEF FINANCIAL OFFICER AGREEMENT", "group_id": "8X47HMp40R2", "group_samples": [{"label": "Contract Chief Financial Officer Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/8X47HMp40R2", "published": true}], "group_size": 1, "tags": [{"name": "Contract Chief Financial Officer Agreement", "type": "category", "uri": "/contracts/tagged/contract-chief-financial-officer-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Georgia", "type": "jurisdiction", "uri": "/contracts/tagged/georgia-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of October 24, 2013, between Biozone Pharmaceuticals, Inc., a Nevada corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a \u201cPurchaser\u201d and collectively, the \u201cPurchasers\u201d).", "id": "90s5G3Knl29", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153613000886/q1101301_ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "October 31st, 2013", "published": true, "pretty": null, "uri": "/contracts/90s5G3Knl29", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "90s5G3Knl29", "group_samples": [{"label": "Securities Purchase Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/90s5G3Knl29", "published": true}], "group_size": 1, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Amendment (\"Amendment'\"). effective as of ________, 2011. modifies the terms of the License Agreement (\"Agreement\") between BioZone Laboratories. Inc. and BetaZone Laboratories LLC dated November 7. 2006.", "id": "93muzkMuoCy", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153611000018/exhibit10_12.htm", "category_name": "License Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "July 7th, 2011", "published": true, "pretty": null, "uri": "/contracts/93muzkMuoCy", "title": "AMENDMENT TO LICENSE AGREEMENT", "group_id": "93muzkMuoCy", "group_samples": [{"label": "License Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/93muzkMuoCy", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Services-business services, nec", "type": "industry", "uri": "/contracts/tagged/services-business-services-nec"}]}, {"intro": "WHEREAS, pursuant to that certain Asset Purchase Agreement, dated as of the date hereof by and among the Company, the Buyer and the Seller (the \u201cPurchase Agreement\u201d), the Seller agrees to assign and transfer to Buyer, and Buyer agrees to purchase, as of the Closing Date, all right, title and interest of Seller under the Contracts and all rights, title and interest of Seller being transferred pursuant to Section 2.1(a) of the Purchase Agreement; and", "id": "97I0dBW7Jti", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000146929911000343/biozoneex102.htm", "category_name": "Assignment and Assumption Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "May 19th, 2011", "published": true, "pretty": null, "uri": "/contracts/97I0dBW7Jti", "title": "ASSIGNMENT AND ASSUMPTION AGREEMENT", "group_id": "97I0dBW7Jti", "group_samples": [{"label": "Assignment and Assumption Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/97I0dBW7Jti", "published": true}], "group_size": 1, "tags": [{"name": "Assignment and Assumption Agreement", "type": "category", "uri": "/contracts/tagged/assignment-and-assumption-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Services-business services, nec", "type": "industry", "uri": "/contracts/tagged/services-business-services-nec"}, {"name": "Florida", "type": "jurisdiction", "uri": "/contracts/tagged/florida-us"}]}, {"intro": "This AGREEMENT AND PLAN OF MERGER (this \u201cAgreement\u201d) is made and entered into as of November 25, 2014 by and among Cocrystal Pharma, Inc., a Delaware corporation (\u201cCocrystal\u201d), Cocrystal Holdings Inc., a Delaware corporation and a wholly owned subsidiary of Cocrystal (the \u201cParent\u201d), Cocrystal Merger Sub., Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (the \u201cCocrystal Merger Sub\u201d), RFS Merger Sub, LLC, a Delaware corporation and wholly-owned subsidiary of Parent (the \u201cRFS Merger Sub\u201d and, together with Cocrystal Merger Sub, the \u201cMerger Subs\u201d), and RFS Pharma, LLC, a Georgia limited liability company (\u201cRFSP\u201d), with respect to the following facts:", "id": "B4WZneCG1v", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588914003751/ex2-1.htm", "category_name": "Merger Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "December 1st, 2014", "published": true, "pretty": null, "uri": "/contracts/B4WZneCG1v", "title": "AGREEMENT AND PLAN OF MERGER BY AND AMONG COCRYSTAL PHARMA, INC., COCRYSTAL HOLDINGS, INC., COCRYSTAL MERGER SUB, INC., RFS MERGER SUB, LLC. AND RFS PHARMA, LLC. Dated as of November 25, 2014", "group_id": "B4WZneCG1v", "group_samples": [{"label": "Merger Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/B4WZneCG1v", "published": true}], "group_size": 1, "tags": [{"name": "Merger Agreement", "type": "category", "uri": "/contracts/tagged/merger-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "Reference is hereby made to that certain Factoring and Security Agreement (\u201cthe Factoring Agreement\u201d), dated as of an approximately even date herewith, by and among Seller and Midland American Capital Corporation. All capitalized terms not otherwise defined herein shall have the meaning ascribed to such term in the Factoring Agreement.", "id": "BWxDAxl4uy", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153613000307/q1101032_ex10-69.htm", "category_name": "Factoring and Security Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "April 1st, 2013", "published": true, "pretty": null, "uri": "/contracts/BWxDAxl4uy", "title": "March ____, 2013", "group_id": "BWxDAxl4uy", "group_samples": [{"label": "Factoring and Security Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/BWxDAxl4uy", "published": true}], "group_size": 1, "tags": [{"name": "Factoring and Security Agreement", "type": "category", "uri": "/contracts/tagged/factoring-and-security-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "THIS EXCLUSIVE LICENSE OPTION AGREEMENT (the \u201cAgreement\u201d) is made and entered into as of September 13, 2011 (\u201cEffective Date\u201d) by and between:", "id": "EaEcM3207W", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588914002511/ex10-22.htm", "category_name": "Exclusive License Option Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "August 14th, 2014", "published": true, "pretty": null, "uri": "/contracts/EaEcM3207W", "title": "EXCLUSIVE LICENSE OPTION AGREEMENT between TEVA PHARMACEUTICAL INDUSTRIES LIMITED and COCRYSTAL DISCOVERY, INC. Dated as of September 13, 2011", "group_id": "EaEcM3207W", "group_samples": [{"label": "Exclusive License Option Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/EaEcM3207W", "published": true}], "group_size": 1, "tags": [{"name": "Exclusive License Option Agreement", "type": "category", "uri": "/contracts/tagged/exclusive-license-option-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This AGREEMENT AND PLAN OF MERGER (this \u201cAgreement\u201d) is made and entered into as of January 2, 2013 by and among Biozone Pharmaceuticals, Inc., a Nevada corporation (\u201cBiozone\u201d), Biozone Acquisitions Co., Inc., a Delaware corporation and wholly-owned subsidiary of Biozone (the \u201cMerger Sub\u201d), and Cocrystal Discovery, Inc., a Delaware corporation (\u201cCocrystal\u201d), with respect to the following facts:", "id": "SNd3aWUs8M", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153614000026/q1101396_ex2-1.htm", "category_name": "Merger Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "January 8th, 2014", "published": true, "pretty": null, "uri": "/contracts/SNd3aWUs8M", "title": "AGREEMENT AND PLAN OF MERGER BY AND AMONG BIOZONE PHARMACEUTICALS, INC., BIOZONE ACQUISITIONS CO., INC. AND COCRYSTAL DISCOVERY, INC. Dated as of January 2, 2014", "group_id": "SNd3aWUs8M", "group_samples": [{"label": "Merger Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/SNd3aWUs8M", "published": true}], "group_size": 1, "tags": [{"name": "Merger Agreement", "type": "category", "uri": "/contracts/tagged/merger-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "THIS NON-RECOURSE PRINCIPAL STOCKHOLDER STOCK PLEDGE AGREEMENT is entered into as of February ___, 2011, by and between [\u25cf], as pledgor (the \u201cPledgor\u201d), and Broadband Capital Management LLC, in its capacity as collateral agent (the \u201cPledgee\u201d) on behalf and for the benefit of the purchasers (the \u201cPurchasers\u201d) signatory to that certain Securities Purchase Agreement (the \"Purchase Agreement\") with International Surf Resorts, Inc. (the \u201cCompany\u201d) dated the date hereof.", "id": "b4baSqqqXbz", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000146929911000123/isrex106.htm", "category_name": "Non-Recourse Principal Stockholder Stock Pledge Agreement", "company_name": "International Surf Resorts, Inc.", "created": "March 1st, 2011", "published": true, "pretty": null, "uri": "/contracts/b4baSqqqXbz", "title": "NON-RECOURSE PRINCIPAL STOCKHOLDER STOCK PLEDGE AGREEMENT", "group_id": "b4baSqqqXbz", "group_samples": [{"label": "Non Recourse Principal Stockholder Stock Pledge Agreement (International Surf Resorts, Inc.)", "uri": "/contracts/b4baSqqqXbz", "published": true}], "group_size": 1, "tags": [{"name": "Non-Recourse Principal Stockholder Stock Pledge Agreement", "type": "category", "uri": "/contracts/tagged/non-recourse-principal-stockholder-stock-pledge-agreement"}, {"name": "International Surf Resorts, Inc.", "type": "company", "uri": "/company/1412486/international-surf-resorts-inc"}, {"name": "Services-business services, nec", "type": "industry", "uri": "/contracts/tagged/services-business-services-nec"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "SUBSCRIPTION AGREEMENT (this \u201cAgreement\u201d) made as of November [ ], 2011 between BioZone Pharmaceuticals, Inc., a Delaware corporation (the \u201cCompany\u201d) and [NAME] (including its respective successors and assigns, \u201cSubscriber\u201d).", "id": "bGU8tTZLAkn", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153611000505/q1100286_ex10-1.htm", "category_name": "Subscription Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "December 7th, 2011", "published": true, "pretty": null, "uri": "/contracts/bGU8tTZLAkn", "title": "SUBSCRIPTION AGREEMENT", "group_id": "bGU8tTZLAkn", "group_samples": [{"label": "Subscription Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/bGU8tTZLAkn", "published": true}], "group_size": 1, "tags": [{"name": "Subscription Agreement", "type": "category", "uri": "/contracts/tagged/subscription-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This GUARANTY AND SECURITY AGREEMENT dated as of March ___, 2013, is made by the entities or individuals which have signed below (individually or collectively, \u201cGuarantor\u201d), in favor of Midland American Capital Corporation, a Nevada Corporation (\u201cCreditor\u201d).", "id": "bYYgFatvF2D", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153613000307/q1101032_ex10-68.htm", "category_name": "Guaranty and Security Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "April 1st, 2013", "published": true, "pretty": null, "uri": "/contracts/bYYgFatvF2D", "title": "GUARANTY AND SECURITY AGREEMENT THIS DOCUMENT CONTAINS A WAIVER OF TRIAL BY JURY", "group_id": "bYYgFatvF2D", "group_samples": [{"label": "Guaranty and Security Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/bYYgFatvF2D", "published": true}], "group_size": 1, "tags": [{"name": "Guaranty and Security Agreement", "type": "category", "uri": "/contracts/tagged/guaranty-and-security-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "THIS PLEDGE AND SECURITY AGREEMENT (this \u201cSecurity Agreement\u201d), dated as of February 24, 2012, is made by and between Biozone Pharmaceuticals, Inc., a Nevada corporation (the \u201cGrantor\u201d), and OPKO Health, Inc., as collateral agent (the \u201cCollateral Agent\u201d) on behalf of and for the benefit of the Purchasers as defined in one or more certain Securities Purchase Agreements with the Grantor, dated as of the date hereof (the \u201cPurchase Agreement\u201d) and the Purchasers, together with the Collateral Agent, are collectively referred to herein as the \u201cSecured Parties\u201d).", "id": "bubAjGOaXQn", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153612000160/q1100382_ex10-4.htm", "category_name": "Pledge and Security Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "March 1st, 2012", "published": true, "pretty": null, "uri": "/contracts/bubAjGOaXQn", "title": "PLEDGE AND SECURITY AGREEMENT", "group_id": "bubAjGOaXQn", "group_samples": [{"label": "Pledge and Security Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/bubAjGOaXQn", "published": true}], "group_size": 1, "tags": [{"name": "Pledge and Security Agreement", "type": "category", "uri": "/contracts/tagged/pledge-and-security-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Florida", "type": "jurisdiction", "uri": "/contracts/tagged/florida-us"}]}, {"intro": "This Share Purchase Agreement (the \"Agreement\") is entered into as of September 13, 2011 by and between Cocrystal Discovery, Inc., a Delaware corporation (the \"Company\"), and Teva Pharmaceutical Industries Limited, a limited share company organized under the laws of Israel (\"Teva\"). Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed to such term in Exhibit C attached hereto.", "id": "dGEuSFkKREJ", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588914001531/ex10-20.htm", "category_name": "Share Purchase Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "May 15th, 2014", "published": true, "pretty": null, "uri": "/contracts/dGEuSFkKREJ", "title": "COCRYSTAL DISCOVERY, INC. SHARE PURCHASE AGREEMENT", "group_id": "dGEuSFkKREJ", "group_samples": [{"label": "Share Purchase Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/dGEuSFkKREJ", "published": true}], "group_size": 1, "tags": [{"name": "Share Purchase Agreement", "type": "category", "uri": "/contracts/tagged/share-purchase-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "THIS FACTORING AND SECURITY AGREEMENT is made as of March 22, 2013 by and between BioZone Laboratories, Inc., a California corporation (\u201cSeller\u201d) and Midland American Capital Corporation, a Nevada corporation (\u201cPurchaser\u201d).", "id": "dZYYcOkeF4a", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153613000307/q1101032_ex10-66.htm", "category_name": "Factoring and Security Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "April 1st, 2013", "published": true, "pretty": null, "uri": "/contracts/dZYYcOkeF4a", "title": "FACTORING AND SECURITY AGREEMENT", "group_id": "dZYYcOkeF4a", "group_samples": [{"label": "Factoring and Security Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/dZYYcOkeF4a", "published": true}], "group_size": 1, "tags": [{"name": "Factoring and Security Agreement", "type": "category", "uri": "/contracts/tagged/factoring-and-security-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Stock Purchase Agreement (\u201cAgreement\u201d) is entered into on June 30, 2011, between __________, an individual with an address at ______________________________ ____________________________ (\u201cSeller\u201d) and Biozone Pharmacuticals, Inc., a Nevada corporation, with an address at 4400 Biscayne Boulevard, Miami, Florida 33137 (\u201cBuyer\u201d).", "id": "evRhCHSujhk", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153611000018/exhibit10_2.htm", "category_name": "Stock Purchase Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "July 7th, 2011", "published": true, "pretty": null, "uri": "/contracts/evRhCHSujhk", "title": "STOCK PURCHASE AGREEMENT BETWEEN AS SELLER AND BIOZONE PHARMACEUTICALS, INC. AS BUYER BIOZONE LABORATORIES, INC.", "group_id": "evRhCHSujhk", "group_samples": [{"label": "Stock Purchase Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/evRhCHSujhk", "published": true}], "group_size": 1, "tags": [{"name": "Stock Purchase Agreement", "type": "category", "uri": "/contracts/tagged/stock-purchase-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Services-business services, nec", "type": "industry", "uri": "/contracts/tagged/services-business-services-nec"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS SECURITIES PURCHASE AGREEMENT (the \u201cAgreement\u201d) is entered into as of this _________ day of November, 2017 (the \u201cEffective Date\u201d) between the parties on the signature page to this Agreement (each, a \u201cPurchaser\u201d), and Cocrystal Pharma, Inc., a Delaware corporation (\u201cCOCP\u201d) (collectively, the Purchaser and COCP are the \u201cParties\u201d).", "id": "ey8EUZ0hJWk", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000149315217014080/ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "December 1st, 2017", "published": true, "pretty": null, "uri": "/contracts/ey8EUZ0hJWk", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "ey8EUZ0hJWk", "group_samples": [{"label": "Securities Purchase Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/ey8EUZ0hJWk", "published": true}], "group_size": 1, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "THIS NOTE AND THE SHARES OF CAPITAL STOCK ISSUABLE UPON ANY CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE \"SECURITIES ACT\"), OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED TO ANY PERSON, INCLUDING A PLEDGEE, UNLESS (1) EITHER (A) A REGISTRATION STATEMENT WITH RESPECT THERETO SHALL BE EFFECTIVE UNDER THE SECURITIES ACT, OR (B) THE COMPANY SHALL HAVE RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT IS AVAILABLE, AND (2) THERE SHALL HAVE BEEN COMPLIANCE WITH ALL APPLICABLE STATE SECURITIES OR \"BLUE SKY\" LAWS.", "id": "fFHh2nQtH1", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153612000615/q1100606_ex10-1.htm", "category_name": "Promissory Note", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "July 5th, 2012", "published": true, "pretty": null, "uri": "/contracts/fFHh2nQtH1", "title": "Contract", "group_id": "fFHh2nQtH1", "group_samples": [{"label": "Promissory Note (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/fFHh2nQtH1", "published": true}], "group_size": 1, "tags": [{"name": "Promissory Note", "type": "category", "uri": "/contracts/tagged/promissory-note"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Nevada", "type": "jurisdiction", "uri": "/contracts/tagged/nevada-us"}]}, {"intro": "This Termination of Executive Employment Agreement (this \"Agreement\") between Cocrystal Pharma, Inc., a Delaware corporation (f/k/a Biozone Pharmaceuticals, Inc.) (including its successors and assigns, the \"Company\"), and Dr. Gary Wilcox (the \"Executive\") is dated as of February 23, 2015. This Agreement terminates the Executive Employment Agreement dated as of January 2, 2014 by and between the Company and Executive (the \"Employment Agreement\"). Capitalized terms used but not defined herein shall have the meanings given to such terms in the Employment Agreement. All references to Sections herein shall be references to such Sections in the Employment Agreement unless otherwise noted.", "id": "fxX7i151mDu", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588915001157/ex10-5.htm", "category_name": "Termination of Executive Employment Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "March 31st, 2015", "published": true, "pretty": null, "uri": "/contracts/fxX7i151mDu", "title": "TERMINATION OF EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "fxX7i151mDu", "group_samples": [{"label": "Termination of Executive Employment Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/fxX7i151mDu", "published": true}], "group_size": 1, "tags": [{"name": "Termination of Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/termination-of-executive-employment-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Washington", "type": "jurisdiction", "uri": "/contracts/tagged/washington-us"}]}, {"intro": "", "id": "gjUlY9aOsZ2", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000141588916005699/ex10-16.htm", "category_name": "Employment Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "April 29th, 2016", "published": true, "pretty": null, "uri": "/contracts/gjUlY9aOsZ2", "title": "Contract", "group_id": "gjUlY9aOsZ2", "group_samples": [{"label": "Employment Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/gjUlY9aOsZ2", "published": true}], "group_size": 1, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Washington", "type": "jurisdiction", "uri": "/contracts/tagged/washington-us"}]}, {"intro": "", "id": "gk1cke3viZi", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153613000747/q1101239_ex10-4.htm", "category_name": "Pledge and Security Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "August 30th, 2013", "published": true, "pretty": null, "uri": "/contracts/gk1cke3viZi", "title": "August 26, 2013", "group_id": "gk1cke3viZi", "group_samples": [{"label": "Pledge and Security Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/gk1cke3viZi", "published": true}], "group_size": 1, "tags": [{"name": "Pledge and Security Agreement", "type": "category", "uri": "/contracts/tagged/pledge-and-security-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This Second Amendment (the \u201cSecond Amendment\u201d), effective as of June 29, 2011, modifies the terms of the License Agreement (the \u201cLicense\u201d) between BioZone Laboratories, Inc. (\u201cBioZone Labs\u201d) and BetaZone Laboratories, LLC (\u2018BetaZone Labs or Licensee\u201d) dated as of November 7, 2006 as modified by the Amendment to the License Agreement between BioZone Pharmaceutical, Inc. (\u201cBPI\u201d) and BetaZone Labs (the \u201cFirst Amendment\u201d) effective as of April [ ], 2011. All terms used herein shall have the definition applied to such terms in the License and the First Amendment.", "id": "gzxIHrb8LpE", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000152153611000018/exhibit10_13.htm", "category_name": "License Agreement", "company_name": "Biozone Pharmaceuticals, Inc.", "created": "July 7th, 2011", "published": true, "pretty": null, "uri": "/contracts/gzxIHrb8LpE", "title": "SECOND AMENDMENT TO LICENSE AGREEMENT BETWEEN BIOZONE LABORATORIES, INC AND BETAZONE LABORATORIES, LLC", "group_id": "gzxIHrb8LpE", "group_samples": [{"label": "License Agreement (Biozone Pharmaceuticals, Inc.)", "uri": "/contracts/gzxIHrb8LpE", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Biozone Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1412486/biozone-pharmaceuticals-inc"}, {"name": "Services-business services, nec", "type": "industry", "uri": "/contracts/tagged/services-business-services-nec"}]}, {"intro": "", "id": "h5cX2PM4GOy", "source_url": "https://www.sec.gov/Archives/edgar/data/1412486/000149315219003950/ex10-1.htm", "category_name": "Equity Distribution Agreement", "company_name": "Cocrystal Pharma, Inc.", "created": "March 26th, 2019", "published": true, "pretty": null, "uri": "/contracts/h5cX2PM4GOy", "title": "Cocrystal Pharma, Inc. 19805 N. Creek Parkway Bothell, WA 98011 March 20, 2019", "group_id": "h5cX2PM4GOy", "group_samples": [{"label": "Equity Distribution Agreement (Cocrystal Pharma, Inc.)", "uri": "/contracts/h5cX2PM4GOy", "published": true}], "group_size": 1, "tags": [{"name": "Equity Distribution Agreement", "type": "category", "uri": "/contracts/tagged/equity-distribution-agreement"}, {"name": "Cocrystal Pharma, Inc.", "type": "company", "uri": "/company/1412486/cocrystal-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}], "next_curs": "CjEKEAoKZ3JvdXBfc2l6ZRICCAEKGQoIZ3JvdXBfaWQSDRoLaDVjWDJQTTRHT3kYACAB", "cursor": "CjEKEAoKZ3JvdXBfc2l6ZRICCAEKGQoIZ3JvdXBfaWQSDRoLNE0xWVdBUXRHbzUYACAB"}}